References concerning ASAT and ALAT
l
IFCC Expert Panel on Enzyrnes. Part 2. IFCC Method for
L-Aspartate Aminotransferase (EC 2.6.1.1). Approved re–
commendation (1985)
J
Clin Chem Clin Biochem 1986; 24: 497 - 510
2
IFCC Expert Panel on Enzyrnes. Part 3. IFCC Method for
Alanine Aminotransferase (EC 2.6.1.2). Approved recom–
mendation (1985)
J
Clin Chem Clin Biochem 1986; 24: 481 - 495
3
Hamfeldt A. The Effect of Pyridoxal Phosphate on the
Aminotransferase activity in Blood.
Scand
J
Clin Lab Invest 1966; 18 (Suppl 92: 181 -
4
Schmidt E and Schmidt F
w.
Optimale Bedingungen zur Bes–
timmuns der Transaminasen und der
Kreat~n-Phosphokinase
im Serum und ihre Konsequenzen f Ur die Diagnostik
z.
Analyt Chemie 1968; Vol 243: 398 - 414
5
H~rder
M, Moore R and Bowers G N. Aspartate Amintransfe–
rase Activity in Human Serum. Factors to Be Considered
in Supplementation with Pyridoxal-5'-Phosphate in Vitra.
Clin Chem 1976; 22: 1876 - 1883
6
Westerhuis L W
J J
M and Hafkenscheid
J
C M.
Apoenzyme
Content of Serum Aminotransferases in Relation to Plasma
Pyridoxal-5'-Phosphate Concentraticn.
Clin Chem 1983; 29: 789 - 792.
7
Arbeitsgruppe Enzyme der
Ko~~ission
fUr Standardisierung
der Deutschen Gesellschaft fUr Klinische Chemie (Perso–
nal communication, 1987)
8
Hafkenscheid
J
C M (Personal ccmmunication l987)
70
Klinisk kemi i Norden 2: suppl, 1990
